Neogen Corp (NEOG) income statement
NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3053% above fair value
$11.08+0.18 (+1.65%)
Close on Nov 18, 2026Market cap $2.42BP/E –Yield –
Neogen Corp income statement
Ratios
Latest available, balances at Aug 31, 2026
Profitability, TTM
- Gross margin
- 47.4%
- Operating margin
- -0.8%
- Net margin
- -6.3%
- Return on equity, FY2026
- -0.4%
Financial strength
- Current ratio
- 3.90
- Debt to equity
- 0.74
- Debt to assets
- 47.1%
- Cash to current liabilities
- 115.1%
Valuation
- P/E ratio
- –
- Price to sales
- 2.74
- Price to book
- 1.16
- Dividend yield
- –
See a number that looks wrong?